{"id":41306,"date":"2023-01-24T01:14:53","date_gmt":"2023-01-24T01:14:53","guid":{"rendered":"https:\/\/www.sisinternational.com\/?page_id=41306"},"modified":"2026-05-05T16:45:04","modified_gmt":"2026-05-05T20:45:04","slug":"etude-de-marche-du-tourisme-medical","status":"publish","type":"page","link":"https:\/\/www.sisinternational.com\/fr\/competence\/etude-de-marche-du-tourisme-medical\/","title":{"rendered":"Medical Tourism Market Research: Corridor Strategy"},"content":{"rendered":"
\n

\u00c9tude de march\u00e9 sur le tourisme m\u00e9dical<\/a><\/h1>\n
\"\u00c9tudes<\/figure>\n<\/p>\n

Le tourisme m\u00e9dical est une industrie en croissance \u00e0 l\u2019\u00e9chelle mondiale en raison de l\u2019augmentation des co\u00fbts des traitements de sant\u00e9 dans les pays d\u2019origine, de la mondialisation du secteur de la sant\u00e9 et de l\u2019acc\u00e8s croissant au personnel m\u00e9dical qualifi\u00e9 dans le monde entier. Les pays des march\u00e9s \u00e9mergents donnent la priorit\u00e9 \u00e0 cette industrie pour attirer les touristes m\u00e9dicaux et stimuler les exportations des industries de services avanc\u00e9es telles que les secteurs de la sant\u00e9, de la biotechnologie et de la pharmacie.<\/p>\n

Le tourisme m\u00e9dical est d\u00e9fini comme le processus consistant \u00e0 voyager hors du pays de r\u00e9sidence pour recevoir des soins m\u00e9dicaux. Bien que beaucoup identifient le tourisme m\u00e9dical comme des personnes qui voyagent des pays riches vers les pays en d\u00e9veloppement pour recevoir des soins m\u00e9dicaux moins chers, le processus s'applique \u00e9galement \u00e0 la situation inverse dans laquelle des personnes provenant de pays moins d\u00e9velopp\u00e9s se rendent dans des \u00e9conomies riches pour effectuer des op\u00e9rations difficiles \u00e0 r\u00e9aliser dans leur pays d'origine. .<\/p>\n

SIS analyse toutes les opportunit\u00e9s potentielles qu'apporte cette fa\u00e7on de travailler et comment les clients et prestataires potentiels peuvent prosp\u00e9rer et am\u00e9liorer les traitements.<\/p>\n

About the Medical Tourism Market<\/a><\/h2>\n

Le tourisme m\u00e9dical est pr\u00e9sent dans presque tous les pays du monde. Par exemple, les r\u00e9sidents am\u00e9ricains se rendent au Mexique, au Canada ou dans les pays d\u2019Am\u00e9rique centrale et d\u2019Am\u00e9rique du Sud pour b\u00e9n\u00e9ficier de soins de sant\u00e9 moins chers, tandis que les Europ\u00e9ens voyagent en dehors de l\u2019UE ou entre des pays o\u00f9 les prix sont plus bas.<\/p>\n

Certaines des destinations les plus populaires sont Cuba, la Gr\u00e8ce, la Tha\u00eflande, la Cor\u00e9e et la Serbie, car leurs m\u00e9decins et sp\u00e9cialistes sont parmi les meilleurs au monde.<\/p>\n

Les raisons les plus courantes pour lesquelles les gens se rendent dans un autre pays pour des soins m\u00e9dicaux sont\u00a0:<\/p>\n

    \n
  1. Prix (de nombreuses personnes voyagent dans d'autres pays parce qu'elles ne peuvent pas se permettre une assurance m\u00e9dicale seule ou parce que les co\u00fbts de l'intervention sont bien sup\u00e9rieurs \u00e0 leur budget, nous pouvons donc conclure que c'est la principale raison du tourisme m\u00e9dical)<\/li>\n
  2. La l\u00e9galit\u00e9 du service (certains services de sant\u00e9 comme l'avortement ou l'euthanasie sont interdits par la loi dans certains pays, mais pas dans tous)
    Diff\u00e9rences culturelles (beaucoup d'immigr\u00e9s souhaitent \u00eatre trait\u00e9s dans leur pays d'origine, en raison de leurs croyances religieuses)<\/li>\n
  3. Acc\u00e8s aux proc\u00e9dures exp\u00e9rimentales<\/li>\n
  4. Acc\u00e8s \u00e0 des soins de meilleure qualit\u00e9<\/li>\n<\/ol>\n

    Parmi les proc\u00e9dures que les gens d\u00e9cident d'aller dans un autre pays figurent (sans toutefois s'y limiter)\u00a0: les traitements de fertilit\u00e9 (par exemple, maternit\u00e9 de substitution, FIV et technologies de procr\u00e9ation assist\u00e9e), les transplantations d'organes, la chirurgie plastique, les soins dentaires et les traitements exp\u00e9rimentaux contre le cancer.<\/p>\n

    \u00c9tude de march\u00e9 sur le parcours client<\/a> can uncover numerous sources of competitive advantage in the Medical Tourism sector. Customers face numerous benefits and risks in medical tourism and the stakes can be high. Before patients decide to have their procedure done in a foreign country, they often conduct comprehensive in-person and online research to pick the right facility, treatment and medical provider for his or her needs. As these decisions can be outside their domestic medical establishments, the online research that patients conduct is important in their decision making. Furthermore, people who opt for medical tourism often exhaust all available medical treatment options in their home country so they can be a vulnerable group requiring information about benefits and risks. Market Research provides the insight for Medical<\/a> Tourism providers to better serve potential patients.<\/p>\n

    Les complications les plus courantes du tourisme m\u00e9dical comprennent\u00a0:<\/p>\n

      \n
    1. Maladies et risque d'infections \u2013 depuis les complications de la proc\u00e9dure (plaie ou infections d\u00e9riv\u00e9es du donneur) jusqu'aux maladies infectieuses si une personne voyage dans des pays lointains<\/li>\n
    2. R\u00e9sistance aux antibiotiques \u2013 il s\u2019agit d\u2019un risque relativement rare, mais tout touriste m\u00e9dical doit en \u00eatre conscient<\/li>\n
    3. Probl\u00e8mes de communication \u2013 seuls les \u00e9tablissements agr\u00e9\u00e9s peuvent fournir au personnel une connaissance avanc\u00e9e de la langue anglaise ou de la langue maternelle du patient, essentielle pour des soins appropri\u00e9s.<\/li>\n
    4. Voyage en avion \u2013 si les patients prennent l'avion imm\u00e9diatement apr\u00e8s l'op\u00e9ration, ils courent un risque \u00e9lev\u00e9 de caillots sanguins ou d'autres risques de voyage, il est donc conseill\u00e9 d'attendre au moins 10 \u00e0 14 jours avant de rentrer chez eux.<\/li>\n<\/ol>\n<\/div>\n

      Medical \u00c9tude de march\u00e9 touristique<\/a>: How Leading Operators Build Cross-Border Patient Pipelines<\/h1>\n

      Medical tourism market research has shifted from descriptive country profiling to operational intelligence that informs corridor selection, payer partnerships, and clinical specialty positioning. The sophisticated buyers in this category, hospital networks, sovereign health funds, insurer-employer coalitions, and private equity-backed specialty groups, treat patient flow modeling the way airlines treat route economics.<\/p>\n

      The global cross-border patient market spans elective orthopedics, oncology second opinions, fertility, dental, cardiac, and bariatric procedures. Each travels along distinct corridors with distinct economics. Mexico-US dental and bariatric flows behave nothing like Gulf-to-Germany oncology referrals or China-to-Japan precision medicine cases. Treating them as a single market produces unusable forecasts.<\/p>\n

      Why Corridor-Level Medical Tourism Market Research Outperforms Country Reports<\/h2>\n

      Country-level sizing obscures the unit of competition. Patients do not choose Thailand. They choose a specific Bangkok hospital with JCI accreditation, a named surgeon, an English-speaking concierge, and a payer arrangement that covers travel. Corridor analysis isolates origin-destination pairs and decomposes them into procedure mix, payer source, facilitator margin, and length-of-stay economics.<\/p>\n

      The leading operators model corridors the way logistics firms model lanes. Singapore-Indonesia cardiac. Turkey-UK hair restoration and dental. Costa Rica-US dental and orthopedics. Korea-China aesthetic surgery. India-East Africa oncology. Each corridor has a distinct conversion funnel from inquiry to deposit to arrival to follow-up, and the leakage points differ.<\/p>\n

      <\/p>\n

      According to SIS International Research, the operators winning share in mature corridors invest heavily in pre-arrival clinical triage, often a structured remote consultation that qualifies the patient and pre-builds the care plan.<\/span> This single step compresses on-site length of stay, reduces clinical surprises, and lifts deposit-to-arrival conversion materially above facilitator-led alternatives.<\/p>\n

      <\/span><\/p>\n

      The Five Forces Reshaping Cross-Border Patient Flows<\/h2>\n

      Five structural forces govern where the next decade of growth concentrates. Each is measurable and each rewards firms that build proprietary intelligence rather than rely on syndicated reports.<\/p>\n

      Payer integration.<\/strong> Self-funded US employers, UK NHS overflow contracting, and Gulf state-sponsored programs have moved from pilot to procurement. The buyer is no longer the patient. It is a benefits committee or a sovereign health authority running an RFP with bundled-price expectations and outcomes reporting requirements.<\/p>\n

      Accreditation as table stakes.<\/strong> JCI, Temos, and ISO 9001 certifications no longer differentiate. The differentiator is publishing risk-adjusted outcomes by surgeon and procedure, the standard set by Bumrungrad, Anadolu Medical Center, and Apollo Hospitals.<\/p>\n

      Facilitator disintermediation.<\/strong> Hospitals with mature international patient departments, Gleneagles, Asan Medical Center, Hospital Israelita Albert Einstein, are building direct payer relationships and bypassing traditional facilitators on high-margin cases.<\/p>\n

      Telemedicine pre-screening.<\/strong> Remote second opinions have become the top of the funnel. The hospital that captures the second opinion captures a disproportionate share of conversions.<\/p>\n

      Visa, currency, and geopolitical friction.<\/strong> Corridor economics shift quickly with visa policy and exchange rates. Turkey’s lira depreciation rebuilt its dental and aesthetic corridors within two years. Sanctions and travel restrictions can collapse a corridor in a quarter.<\/p>\n

      What Sophisticated Medical Tourism Market Research Actually Measures<\/h2>\n

      Descriptive market sizing is the entry-level deliverable. The intelligence that informs capital allocation goes deeper.<\/p>\n

      \n\n\n\n\n\n\n\n\n\n
      Research Layer<\/th>\nWhat It Measures<\/th>\nDecision It Informs<\/th>\n<\/tr>\n<\/thead>\n
      Corridor sizing<\/td>\nProcedure-level patient volumes by origin-destination pair<\/td>\nMarket entry, capacity planning<\/td>\n<\/tr>\n
      Payer mapping<\/td>\nSelf-pay vs employer-funded vs sovereign-sponsored mix<\/td>\nChannel investment, pricing<\/td>\n<\/tr>\n
      Facilitator economics<\/td>\nCommission structures, lead quality, conversion rates<\/td>\nDirect vs intermediated channel mix<\/td>\n<\/tr>\n
      Clinical outcomes benchmarking<\/td>\nRisk-adjusted complication and revision rates<\/td>\nSpecialty positioning, payer contracting<\/td>\n<\/tr>\n
      Patient journey ethnography<\/td>\nDecision triggers, anxiety points, post-op follow-up gaps<\/td>\nService design, retention<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/figure>\n

      Source: SIS International Research<\/em><\/p>\n

      The patient journey layer is where most market entry decks are weakest. Cross-border patients make decisions across an eight-to-fourteen-week window with multiple household stakeholders, and the conversion-killing moments are rarely clinical. They are visa anxiety, deposit refund policy ambiguity, and post-arrival communication gaps.<\/p>\n

      The SIS Approach to Medical Tourism Market Research<\/h2>\n

      <\/p>\n

      SIS International’s healthcare practice combines structured B2B expert interviews with international patient department directors, ethnographic research with returning patients, and competitive intelligence on hospital pricing, accreditation, and outcomes disclosure. A recent mixed-methodology engagement targeted 200 respondents across Brazil to map inbound and outbound patient flows for a Fortune 500 healthcare client evaluating Latin American corridor expansion.<\/p>\n

      <\/span><\/p>\n

      The healthcare practice has fielded patient-side and provider-side studies across China, Mexico, the United States, Germany, Korea, Singapore, and Israel, including direct CEO-level interviews with overseas medical services agencies serving outbound Chinese patients. This dual-perspective design, capturing both the originating facilitator and the receiving hospital, surfaces the pricing and commission realities that single-sided studies miss.<\/p>\n

      SIS Corridor Viability Framework<\/h3>\n

      Four dimensions determine whether a corridor merits investment.<\/p>\n